Effects of sildenafil on esophageal motility of patients with idiopathic achalasia.
about
Diagnosis and management of paroxysmal nocturnal hemoglobinuriaClinical management of achalasia: current state of the artPharmacotherapy for the management of achalasia: Current status, challenges and future directionsIdiopathic (primary) achalasia: a reviewEffect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disordersSildenafil inhibits gastroduodenal motility.Sildenafil normalizes bowel transit in preclinical models of constipationAchalasia - an update.Laparoscopic cardiomyotomy for achalasia: A single unit studyPhosphodiesterase 5 inhibitors: current status and potential applications.Current approach to the treatment of achalasia.2011 update on esophageal achalasia.Review article: the management of achalasia - a comparison of different treatment modalities.Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy.Cost-assessment of alternative management strategies for achalasia.Relevance of ineffective oesophageal motility during oesophageal acid clearance.Oesophageal motor functions and its disorders.Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction.Management of spastic disorders of the esophagusVardenafil: a selective inhibitor of phosphodiesterase-5 for the treatment of erectile dysfunction.Current status in the treatment options for esophageal achalasia.Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors.ACG clinical guideline: diagnosis and management of achalasia.Treatments for achalasia in 2017: how to choose among them.Is POEM the Answer for Management of Spastic Esophageal Disorders? A Systematic Review and Meta-Analysis.Management of achalasia.Peroral endoscopic myotomy (POEM) vs laparoscopic Heller myotomy (LHM) for the treatment of Type III achalasia in 75 patients: a multicenter comparative study.An Overview of Achalasia and Its Subtypes.Systemic and metabolic effects of PDE5-inhibitor drugsEffect of Sildenafil on hypertensive lower oesophageal sphincter.Allosteric-site and catalytic-site ligand effects on PDE5 functions are associated with distinct changes in physical form of the enzyme.Current clinical approach to achalasia.The effects of sildenafil on rectal sensitivity and tone in patients with the irritable bowel syndrome.Effect of sildenafil, a phosphodiesterase-5 inhibitor, on oesophageal peristalsis and lower oesophageal sphincter function in cats.Influence of sildenafil on gastric sensorimotor function in humans.Saliva transport to the distal esophagus.Expert consensus document: Advances in the management of oesophageal motility disorders in the era of high-resolution manometry: a focus on achalasia syndromes.Sildenafil improves clinical signs and radiographic features in dogs with congenital idiopathic megaoesophagus: a randomised controlled trial.Megaesophagus in an elderly man with achalasia: a "not so benign" condition.Focal achalasia - case report and review of the literature.
P2860
Q24670119-191EB4CC-5AF3-4199-B038-14AFC57F65E4Q26750707-EACD1A76-EFC2-49C5-91EB-50E1B61E868DQ26777632-46DFFD47-7CCA-4DEC-BF60-9BA1A760697AQ26801313-6128DEE9-8DAA-436F-BB2C-F5F7EB676B70Q28217534-BB3CA3B4-593F-433E-96B1-D85F37560878Q31811097-C8AD9AE7-0DE8-41F3-BDED-6137D8C758D1Q33610799-529AAD34-AB6C-4671-9170-DEC10B4F2D09Q34028403-F755D143-62B2-4CD1-B13C-87356363143FQ34125634-2A9698C4-C2E3-4B8C-A1CE-E9F939DD810BQ34147460-0DD0D8C2-0F06-4CEF-AB0B-EE6A9DF54735Q34172430-3BA97883-026F-4F35-9DF0-4FD16160780EQ34270601-24A0DC6C-FB95-40ED-9A0F-8586383EDF5AQ34562734-5EACC168-1CBE-47A8-982C-35DCCF08FD1EQ35126913-5C8440C0-019B-4FAF-AB3A-C8BD124329C7Q35574993-7355F11F-C292-4836-B6D4-D069E20AF896Q35595693-9BA7DB10-AF82-478A-A675-E38B5932386AQ35884378-A2966B88-3EA3-4727-89C9-1B86848D053BQ36572591-F04E051C-93EE-4F74-9D7C-FC16A4503383Q36746436-86DEBEEC-B2D0-407E-8830-41F2FB3FF959Q36808042-B70E62D3-6DBC-4A86-A0E4-AE38B94BD769Q37142188-C4273177-F901-4FEF-B0E2-FAD284A06E8DQ37903037-23775948-AD41-4358-8D34-220095E3A72FQ38123364-9ABD3B82-B35C-49F3-A707-9B65CD4AF5B6Q38828675-4D57981F-AC17-4BBA-B47A-4FFCFA514BACQ39011837-85338387-72F6-4EED-962C-749CC554F1F2Q39736933-BE2F4613-07F3-4299-A527-838DE44AD816Q40740913-82159337-BC71-4313-8E1D-8AE7E2379269Q41531364-5E2C921F-C2E3-41BA-9511-E6C937B00211Q42129412-CF5B9026-7CF2-4AE5-951F-7D9244598F1CQ42528744-FE49FED9-DCB4-4568-8BE0-EFC26F15A0E8Q42581981-F14967DC-8AC6-4D98-AC13-8B9C74F7E59FQ43064086-B4CCAB3D-FC13-425E-97F1-9E9DC0FFE59EQ43338890-366EEB85-3984-4C7B-9EAD-E181183FD92EQ43750385-2ACB1422-0913-4314-8760-165544265918Q45099367-51D58CB7-2EC0-4D6C-8766-D9D28A7DD395Q46741189-9ECAE3CF-82ED-4E5E-98D8-3B288BF075A7Q47670332-D48F467E-2724-4AB8-917C-BE5D9B4ABCDDQ48251165-3466543B-9F15-456F-B263-A9D0C03EFE8EQ48316324-308AD42D-26A0-45B0-96EB-09E152808122Q49205487-B7A8F372-8ED1-4D9B-B9CA-A507D0C8FE18
P2860
Effects of sildenafil on esophageal motility of patients with idiopathic achalasia.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Effects of sildenafil on esophageal motility of patients with idiopathic achalasia.
@en
Effects of sildenafil on esophageal motility of patients with idiopathic achalasia.
@nl
type
label
Effects of sildenafil on esophageal motility of patients with idiopathic achalasia.
@en
Effects of sildenafil on esophageal motility of patients with idiopathic achalasia.
@nl
prefLabel
Effects of sildenafil on esophageal motility of patients with idiopathic achalasia.
@en
Effects of sildenafil on esophageal motility of patients with idiopathic achalasia.
@nl
P2093
P1433
P1476
Effects of sildenafil on esophageal motility of patients with idiopathic achalasia.
@en
P2093
P304
P356
10.1016/S0016-5085(00)70206-X
P407
P577
2000-02-01T00:00:00Z